| Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs ML Kowalski, R Asero, S Bavbek, M Blanca, N Blanca‐Lopez, ... Allergy 68 (10), 1219-1232, 2013 | 604 | 2013 |
| Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA* ML Kowalski, JS Makowska, M Blanca, S Bavbek, G Bochenek, ... Allergy 66 (7), 818-829, 2011 | 575 | 2011 |
| Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper ML Kowalski, I Agache, S Bavbek, A Bakirtas, M Blanca, G Bochenek, ... Allergy 74 (1), 28-39, 2019 | 351 | 2019 |
| Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial WW Busse, ER Bleecker, JM FitzGerald, GT Ferguson, P Barker, ... The lancet respiratory medicine 7 (1), 46-59, 2019 | 291 | 2019 |
| Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects DMF Scalabrin, S Bavbek, MS Perzanowski, BB Wilson, TAE Platts-Mills, ... Journal of allergy and clinical immunology 104 (6), 1273-1279, 1999 | 240 | 1999 |
| Research needs in allergy: an EAACI position paper, in collaboration with EFA NG Papadopoulos, I Agache, S Bavbek, BM Bilo, F Braido, V Cardona, ... Clinical and translational allergy 2, 1-23, 2012 | 239 | 2012 |
| EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders O Boyman, C Kaegi, M Akdis, S Bavbek, A Bossios, A Chatzipetrou, ... Allergy 70 (7), 727-754, 2015 | 163 | 2015 |
| Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study ME Wechsler, A Menzies-Gow, CE Brightling, P Kuna, S Korn, T Welte, ... The Lancet Respiratory Medicine 10 (7), 650-660, 2022 | 126 | 2022 |
| Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: an EAACI statement A Vultaggio, I Agache, CA Akdis, M Akdis, S Bavbek, A Bossios, ... Allergy 75 (11), 2764-2774, 2020 | 117 | 2020 |
| The prevalence of allergic diseases and atopy in Ankara, Turkey: a two-step population-based epidemiological study G Çelik, D Mungan, S Bavbek, B Sin, D Ediger, Y Demirel, Z Misirlgil Journal of Asthma 36 (3), 281-290, 1999 | 100 | 1999 |
| Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity MJ Torres, A Trautmann, I Böhm, K Scherer, A Barbaud, S Bavbek, ... Allergy 76 (5), 1325-1339, 2021 | 97 | 2021 |
| Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leucocytes in aspirin‐induced … G Celik, S Bavbek, Z Misirligil, M Melli Clinical & Experimental Allergy 31 (10), 1615-1622, 2001 | 93 | 2001 |
| Use of alternative medicines by allergic patients in Turkey E Kurt, S Bavbek, G Pasaoglu, O Abadoglu, Z Misirligil Allergologia et immunopathologia 32 (5), 289-294, 2004 | 90 | 2004 |
| Hypersensitivity reactions to chemotherapy: an EAACI position paper M Pagani, S Bavbek, E Alvarez‐Cuesta, A Berna Dursun, P Bonadonna, ... Allergy 77 (2), 388-403, 2022 | 85 | 2022 |
| The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance S Bavbek, G Çelik, D Ediger, D Mungan, YS Demirel, Z Misirhgil Journal of Asthma 36 (8), 657-663, 1999 | 85 | 1999 |
| Safety of selective COX‐2 inhibitors in aspirin/nonsteroidal anti‐inflammatory drug‐intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib S Bavbek, G Çelik, F Özer, D Mungan, Z Mısırlıgil Journal of Asthma 41 (1), 67-75, 2004 | 82 | 2004 |
| Allergies and COVID‐19 vaccines: an ENDA/EAACI position paper A Barbaud, LH Garvey, A Arcolaci, K Brockow, F Mori, C Mayorga, ... Allergy 77 (8), 2292-2312, 2022 | 81 | 2022 |
| Drug allergy passport and other documentation for patients with drug hypersensitivity–an ENDA/EAACI Drug Allergy Interest Group Position Paper K Brockow, W Aberer, M Atanaskovic‐Markovic, S Bavbek, A Bircher, ... Allergy 71 (11), 1533-1539, 2016 | 80 | 2016 |
| Characteristic features of cockroach hypersensitivity in Turkish asthmatic patients D Mungan, G Çelik, B Sin, S Bavbek, Y Demirel, Z Misirligil Allergy 53 (9), 870-873, 1998 | 78 | 1998 |
| Psychological status of patients with chronic urticaria G Pasaoglu, S Bavbek, H Tugcu, O Abadoglu, Z Misirligil The journal of dermatology 33 (11), 765-771, 2006 | 76 | 2006 |
